SCHEMBL6306264

SCHEMBL6306264

Cc1nc2cc(Cl)c(Cl)cc2[nH]c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 6/20 0.58
GRIN3B O60391 6/20 0.58
GRIN1 Q05586 6/20 0.58
GRIN2A Q12879 6/20 0.58
GRIN2B Q13224 6/20 0.58
GRIN2C Q14957 6/20 0.58
GRIN3A Q8TCU5 6/20 0.58
GRIA1 P42261 5/20 0.58
GRIA2 P42262 5/20 0.58
GRIA3 P42263 5/20 0.58
GRIA4 P48058 5/20 0.58
LMNA P02545 2/20 0.58
GRIK1 P39086 2/20 0.58
GRIK2 Q13002 2/20 0.58
GRIK3 Q13003 2/20 0.58
GRIK4 Q16099 2/20 0.58
GRIK5 Q16478 2/20 0.58
HRH4 Q9H3N8 1/20 0.54
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11370785 0.81 GRIN2D (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7345144 0.81 GRIN2D (0.62) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6304037 0.79 HRH4 (0.56) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6311370 0.79 ALDH1A1 (0.64) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL6304503 0.78 KDM4E (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8872580 0.78 MEN1 (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL5774932 0.77 GRIN2D (0.54) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL316047 0.76 ALDH1A1 (0.60) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL14765197 0.74 MAPT (0.56) KDM4EMEN1ALDH1A1CYP1A2MAPT
SCHEMBL14764938 0.74 PIN1 (0.56) KDM4EALDH1A1CYP1A2MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4181724-A Quinoxalinone compounds useful for expanding the lumina or air passages in mammals THE UPJOHN COMPANY (US) 1980-01-01 US claimed
US-6927214-B1 Non-peptide GLP-1 agonists NOVO NORDISK A/S (DK) 2005-08-09 US disclosed
EP-1147094-A1 NON-PEPTIDE GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2001-10-24 EP disclosed
WO-2000042026-A1 NON-PEPTIDE GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2000-07-20 WO disclosed